The leukemia team at the Gill Center gives patients and their families what they need, when they need it: prompt diagnoses and exceptional care, access to the most advanced treatment protocols and nationally recognized leaders in pediatric leukemia research.
Between 60 and 80 new patients enter the program each year. We treat every type of leukemia seen in children and adolescents, ranging from common to exceptionally rare.
Specific subtypes include:
- T- and B-precursor acute lymphoblastic leukemias
- Infant leukemia
- Transient myeloproliferative disease
- Acute and chronic myeloid leukemia
- Burkitt’s leukemia
- Rare histologies, including acute blastic plasmacytoid neoplasms
Patients enrolled in our program beneft from a multidisciplinary approach, including weekly leukemia team meetings where specialists and subspecialists review new patients, patients with treatment-related issues, patients following relapse and patients receiving standard therapies. Both patients and families benefit from the involvement of the Gill Center’s nurses, nurse practitioners, physician assistants, social workers, child life specialists, play therapists, psychologists, nutritionists, massage and aroma therapists, teachers, music therapists, chaplains, professional clowns and pain specialists.
- Between 60 and 80 new patients enrolled annually
- Multidisciplinary approach, including care for the entire family
- Exceptional monitoring and tracking of therapy doses
- Active enrollment of all patients in the Children’s Oncology Group and Therapeutic Advances in
- Childhood Leukemia (TACL) trials
- See also Stem Cell Transplant Program